ERIC JONASCH to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications ERIC JONASCH has written about Xenograft Model Antitumor Assays.
Connection Strength
0.121
-
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. 2016 05; 35(21):2687-97.
Score: 0.073
-
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer. Cancer Cell. 2020 03 16; 37(3):371-386.e12.
Score: 0.025
-
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake. Commun Biol. 2019; 2:386.
Score: 0.024